71 related articles for article (PubMed ID: 25408262)
1. Pharmacokinetic properties of two erlotinib 150 mg formulations with a genetic effect evaluation in healthy Korean subjects.
Choi HG; Jeon JY; Im YJ; Kim Y; Song EK; Seo YH; Cho SJ; Kim MG
Clin Drug Investig; 2015 Jan; 35(1):31-43. PubMed ID: 25408262
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and bioequivalence of tofacitinib 5 mg in healthy Korean male subjects.
Lee JH; Jeon JY; Jang K; Kang SK; Kwak YG; Moon SJ; Kim MG
Int J Clin Pharmacol Ther; 2024 Mar; 62(3):142-148. PubMed ID: 38174885
[TBL] [Abstract][Full Text] [Related]
3. Effect of food on the pharmacokinetic profile of etamicastat (BIA 5-453).
Vaz-da-Silva M; Nunes T; Rocha JF; Falcão A; Almeida L; Soares-da-Silva P
Drugs R D; 2011; 11(2):127-36. PubMed ID: 21548660
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and pharmacodynamic evaluation study of etomidate: a randomized, open-label, 2-period crossover study in healthy Chinese subjects.
Ding Y; Chu NN; Wang R; Qin W; Shi YF; Qian ZZ; Liu B; He Q
Sci Rep; 2024 Mar; 14(1):7071. PubMed ID: 38528026
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the pharmacokinetic characteristics and bioequivalence between two nanosuspension formulations of megestrol acetate in healthy Korean male subjects.
Park SR; Hwang JG; Jeong SI; Choi YS; Min HJ; Kim HY; Choi BH; Park MK
Transl Clin Pharmacol; 2024 Mar; 32(1):63-72. PubMed ID: 38586120
[TBL] [Abstract][Full Text] [Related]
6. Bioequivalence Assessment of Two Dapoxetine Hydrochloride Formulations in Healthy Chinese Males Under Fasted and Fed Conditions.
Li Y; Zhang Z; Xie J; Lian X; Zhang G; Wang C
Clin Pharmacol Drug Dev; 2024 Feb; ():. PubMed ID: 38396214
[TBL] [Abstract][Full Text] [Related]
7. Comparative pharmacokinetics of two formulations of 2.5-mg rivaroxaban in healthy Korean subjects.
Moon SJ; Kim Y; Kim SY; Jeon JY; Song E; Lim Y; Kim MG
Int J Clin Pharmacol Ther; 2023 Mar; ():. PubMed ID: 36871246
[TBL] [Abstract][Full Text] [Related]
8. Comparative Pharmacokinetic Profiles of a Novel Low-Dose Micronized Formulation of Raloxifene 45 mg (AD-101) and the Conventional Raloxifene 60 mg in Healthy Subjects.
Lee HW; Kang WY; Gwon MR; Park SJ; Cho K; Seong SJ; Yoon YR
Clin Pharmacol Drug Dev; 2023 Dec; 12(12):1204-1210. PubMed ID: 37622634
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of a Novel Anagrelide Extended-Release Formulation in Healthy Subjects: Food Intake and Comparison With a Reference Product.
Petrides PE; Schoergenhofer C; Widmann R; Jilma B; Klade CS
Clin Pharmacol Drug Dev; 2018 Feb; 7(2):123-131. PubMed ID: 28301098
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic and Safety Study of Bismuth Potassium Citrate Formulations in Healthy Subjects.
Luo HY; Xu SG; Gao LC; Long HZ; Zhou ZW; Li FJ; Dai SM; Hu JD; Su Y; Cheng Y
Drugs R D; 2024 Mar; 24(1):81-87. PubMed ID: 38345697
[TBL] [Abstract][Full Text] [Related]
11. Randomised, crossover clinical trial, in healthy volunteers, to compare the systemic availability of two topical intranasal budesonide formulations.
Algorta J; Pena MA; Francisco S; Abajo Z; Sanz E
Trials; 2008 Jun; 9():34. PubMed ID: 18541030
[TBL] [Abstract][Full Text] [Related]
12. A Semi-Mechanistic Population Pharmacokinetic Model of Noscapine in Healthy Subjects Considering Hepatic First-Pass Extraction and CYP2C9 Genotypes.
Chen Z; Taubert M; Chen C; Boland J; Dong Q; Bilal M; Dokos C; Wachall B; Wargenau M; Scheidel B; Wiesen MHJ; Schaeffeler E; Tremmel R; Schwab M; Fuhr U
Drugs R D; 2024 May; ():. PubMed ID: 38809387
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of model-based bioequivalence approach for single sample pharmacokinetic studies.
Tardivon C; Loingeville F; Donnelly M; Feng K; Sun W; Sun G; Grosser S; Zhao L; Fang L; Mentré F; Bertrand J
CPT Pharmacometrics Syst Pharmacol; 2023 Jul; 12(7):904-915. PubMed ID: 37114321
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and tolerability of a veterinary phenobarbital product in healthy dogs.
Jukier T; Gross A; Boothe D
Front Vet Sci; 2023; 10():1307888. PubMed ID: 38249559
[TBL] [Abstract][Full Text] [Related]
15. Amitriptyline pharmacokinetics in experimental spinal cord injury in the rabbit.
Reihanikermani H; Ansari M; Soltani A; Meymandi MS
Indian J Pharm Sci; 2008 Nov; 70(6):782-5. PubMed ID: 21369441
[TBL] [Abstract][Full Text] [Related]
16. Bioavailability study of calcium sandoz-250 by atomic absorption spectroscopy in albino rats.
Patel BN; Krishnaveni N; Jivani NP; Khodakiya AS; Khodakiya MS; Parida SK
Ayu; 2014; 35(4):438-41. PubMed ID: 26195909
[TBL] [Abstract][Full Text] [Related]
17. Screening study for genetic polymorphisms affecting pharmacokinetics of talniflumate.
Jin LH; Kim BH; Lee JH; Lee K; Kwack K; Yim SV
Transl Clin Pharmacol; 2017 Dec; 25(4):166-172. PubMed ID: 32095470
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic properties of isosorbide-5-mononitrate under fasting and fed conditions in healthy male subjects.
Jin C; Jeon JY; Im YJ; Jeong JA; Kim Y; Chae SW; Bentz J; Kumke T; Kim MG
Int J Clin Pharmacol Ther; 2015 Jan; 53(1):97-106. PubMed ID: 25492848
[TBL] [Abstract][Full Text] [Related]
19. Integration of liquid biopsy and pharmacogenomics for precision therapy of EGFR mutant and resistant lung cancers.
Kolesar J; Peh S; Thomas L; Baburaj G; Mukherjee N; Kantamneni R; Lewis S; Pai A; Udupa KS; Kumar An N; Rangnekar VM; Rao M
Mol Cancer; 2022 Feb; 21(1):61. PubMed ID: 35209919
[TBL] [Abstract][Full Text] [Related]
20. Genotypes Affecting the Pharmacokinetics of Anticancer Drugs.
Bertholee D; Maring JG; van Kuilenburg AB
Clin Pharmacokinet; 2017 Apr; 56(4):317-337. PubMed ID: 27641154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
